" class="no-js "lang="en-US"> NovAliX - Medtech Alert
Saturday, September 13, 2025
NovAliX | Pharmtech Focus

NovAliX

About NovAliX

NovAliX

NovAliX provides small molecule DRUG DISCOVERY services; serving pharmaceutical companies via a unique combination of screening, medicinal chemistry & structural biology. Clients from all over the world, in key industrial sectors, rely upon the laboratories of NovAliX to deliver the innovations that future business growth depends upon through the successful completion of challenging projects.

It is the personal support of the individual professionals that builds secure corporate relationships. The expertise of NovAliX ensures that our clients meet their targeted objectives.

Synthetic organic & medicinal CHEMISTRY: 1) Hit to lead & lead optimization 2) Focused libraries for drug discovery 3) Process research -new practical routes 4) Custom synthesis of chemicals & reference materials 5) Cost competitive FFS/FTEs

BIOPHYSICAL toolbox: 1) Crystallographic grade protein 2) Target-ligand crystal structures by XRD – large gallery 3) Native MS screening up to 2000 compounds per day 4) Binding parameters measured by SPR (Biacore), ITC, NMR 5) Cryo electron microscopy

Medicinal chemists: guide optimisation from hit to clinic.

Related Story

NovAliX Signs Partnership Agreement to Design and Screen Sanofi’s New DNA-Encoded Libraries

November 30 2021

NovAliX, a Contract Research Organization (CRO) specializing in drug research and development, today announces its […]